The second-generation quinolone ofloxacin interferes with the screening test of porphyrins.
The second-generation quinolone ofloxacin interferes with the screening test of porphyrins.
We observed a 20-fold increase in the porphyrin concentration measured in urine of an ofloxacin-treated patient, compared with drug-free normal urine. Two other fluorinated 4-quinolones tested, norfloxacin and ciprofloxacin, had a less marked effect (a twofold increase), whereas the first-generation quinolone, nalidixic acid, did not affect the measured porphyrin concentration at all. The interference is probably due to the overlap in the emission fluorescence spectra of ofloxacin and urinary porphyrins at -600 nm.
To avoid a false-positive diagnosis of porphyria, we suggest using HPLC to separate ofioxacin (10-mm retention time) from urinary porphyrins (which only start to elute at 12 mm). Nonetheless, given a threefold increase in urinary porphyrins observed in the urine of an ofloxacintreated patient, we also discuss a possible interference of the drug with the metabolism of porphyrins. All other reagents were of the highest purity available.
Materials and Methods Materials

Screening Test
The urine was diluted 10-fold in 0. A, -) and the peak of a uroporphynn standard (B) were also collected and scanned. 
